PFA
EMN icon

Pathway Financial Advisers’s Eastman Chemical EMN Stock Holding History

Pathway Financial Advisers’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-51
Closed -$4.64K – 224
2024
Q4 		$4.64K Sell
51
-5,592
-99% -$573K ﹤0.01% 403
2024
Q3 		$50 Buy
+5,643
New +$564K ﹤0.01% 413

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pathway Financial Advisers's EMN Position: Q1 2025 in Review

Pathway Financial Advisers sold out of Eastman Chemical (EMN) in Q1 2025, closing a stake of 51 shares — an estimated $4.64K sold.

Pathway Financial Advisers first reported a position in EMN in Q3 2024 and held it in 2 quarters. The position peaked at $4.64K in Q4 2024. 806 funds tracked by Wall St. Rank hold EMN as of Q1 2025.

  • Pathway Financial Advisers reported no remaining Eastman Chemical position as of Q1 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 51 Eastman Chemical shares in Q1 2025, an estimated $4.64K.
  • Pathway Financial Advisers first reported a position in Eastman Chemical in Q3 2024 and held it in 2 quarters.
  • Pathway Financial Advisers's Eastman Chemical position peaked at $4.64K in Q4 2024.
  • 806 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2025.

Based on Pathway Financial Advisers's 13F filing for Q1 2025, filed 9 May 2025.